A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback